- Home
- applications
- therapeutics unveils model development
Show results for
Refine by
Therapeutics Unveils Model Development Product Applications
8 applications found
Premium
Discover a high-throughput flow imaging microscopy platform for characterizing API aggregates and other particulates in your protein, monoclonal antibody, or antibody-drug conjugate ...
ByYokogawa Fluid Imaging Technologies, Inc. based in Scarborough, MAINE (USA)
AlNovo is applying our Novobinder technology to better understand the processes of pathogenesis and to drive improved outcomes in precision ...
ByAinovo Biotech Inc. based in Sacramento, CALIFORNIA (USA)
Antibiotic resistance is the most insidious public health challenge of our time. AINovo discovers novel therapeutics to alleviate the burden of antibiotic-resistance and battle emerging pathogenic ...
ByAinovo Biotech Inc. based in Sacramento, CALIFORNIA (USA)
AlNovo is pioneering new therapeutic modalities based on our Novobinder Platform to harness the power of the human immune system to directly attack cancer ...
ByAinovo Biotech Inc. based in Sacramento, CALIFORNIA (USA)
NorthStar Medical Radioisotopes is poised to become the first-in-class supply chain for the future of therapeutic radiopharmaceuticals. Check back for progress on our non-carrier-added (n.c.a) Ac-225 and Cu-67 development ...
ByNorthStar Medical Radioisotopes, LLC based in Beloit, WISCONSIN (USA)
In cell therapy, the source and quality of albumin has proven important for both performance and regulatory purposes. Albumedix' recombinant human albumin products are used in a range of cell therapy media and products offering increased viability, consistency and ...
BySartorius AG based in Goettingen, GERMANY
Deliver the right cells to the patient on time. Maximize Functional Characterization of Your Precious T Cell Samples. The Opto™ Cell Therapy Development workflow accelerates the creation of better therapeutics by performing multiple functional assays across 1,000s of individual T cells in a matter of days. Deeply characterize, profile, and map your T cell populations at the single-cell level to directly link phenotype to gene ...
ByBruker Corporation based in Billerica, MASSACHUSETTS (USA)
Fractyl Health was founded in 2011 with a dedication to developing novel therapeutic interventions that have the potential to help reverse the metabolic disease epidemic. Despite advances in treatment over the past 50 years, metabolic diseases in general, and type 2 diabetes (T2D) in particular, continue to be a principal and rapidly growing driver of morbidity and mortality in the 21st century. Our goal is to transform T2D treatment from chronic blood glucose management to disease-modifying therapies that target ...
ByFractyl Health based in Lexington, MASSACHUSETTS (USA)